Literature DB >> 27941174

Nocturnal levels of chemerin and progranulin in adolescents: influence of sex, body mass index, glucose metabolism and sleep.

Johann Daxer, Theresa Herttrich, Ying Y Zhao, Mandy Vogel, Andreas Hiemisch, Kathrin Scheuermann, Antje Körner, Jürgen Kratzsch, Wieland Kiess, Mirja Quante.   

Abstract

BACKGROUND: Adipokines have been implicated in obesity, insulin resistance and sleep regulation. However, the role of chemerin and progranulin, two recently described adipokines, in the context of sleep remains unclear. The aim of this study was to compare nocturnal serum chemerin and progranulin levels between overweight/obese and normal-weight adolescents and to assess variations by sex, across different sleep stages and in relation to glucose metabolism.
METHODS: The study sample included 34 overweight/obese and 32 normal-weight adolescents from secondary schools and the Leipzig Research Center for Civilization Diseases (LIFE) Child study cohort. We obtained longitudinal serum adipokine levels during in-laboratory polysomnography followed by an oral glucose tolerance test.
RESULTS: Overweight/obese adolescents had significantly higher mean nocturnal serum chemerin area under the curve (AUC) levels (348.2±133.3 vs. 241.7±67.7 vs. ng/mL×h, p<0.001) compared to normal-weight controls. In detail, higher chemerin AUC levels in obese/overweight subjects were exclusively due to increased levels in females. No overall difference for serum progranulin AUC was found between the groups. However, when assessing sex-specific levels, serum progranulin AUC levels were ~30% higher in overweight/obese males compared to overweight/obese females. Of note, nocturnal serum chemerin and progranulin AUC did not exhibit a correlation with markers of glucose metabolism or sleep stages.
CONCLUSIONS: Collectively, we report a sexual dimorphism in nocturnal progranulin and chemerin levels, which may help explain underlying differences in energy balance and body composition between males and females in the context of obesity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27941174     DOI: 10.1515/jpem-2016-0378

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  9 in total

1.  Sleep Characteristics and Cerebrospinal Fluid Progranulin in Older Adults: The CABLE Study.

Authors:  Meng Wang; Fu-Rong Sun; Yan-Lin Bi; Ya-Hui Ma; Jian-Jun Yin; Xue-Ning Shen; Xiao-Tong Wang; Lan Tan; Jin-Tai Yu
Journal:  Neurotox Res       Date:  2021-01-14       Impact factor: 3.911

2.  The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension.

Authors:  Stephanie W Watts; Emma S Darios; Adam E Mullick; Hannah Garver; Thomas L Saunders; Elizabeth D Hughes; Wanda E Filipiak; Michael G Zeidler; Nichole McMullen; Christopher J Sinal; Ramya K Kumar; David J Ferland; Gregory D Fink
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

Review 3.  Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population.

Authors:  Thomas Reinehr; Christian Ludwig Roth
Journal:  Curr Diab Rep       Date:  2018-10-18       Impact factor: 4.810

4.  Higher Lipopolysaccharide Binding Protein and Chemerin Concentrations Were Associated with Metabolic Syndrome Features in Pediatric Subjects with Abdominal Obesity during a Lifestyle Intervention.

Authors:  Amelia Marti; Isabel Martínez; Ana Ojeda-Rodríguez; María Cristina Azcona-Sanjulian
Journal:  Nutrients       Date:  2021-01-20       Impact factor: 5.717

Review 5.  Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Douglas G Walker
Journal:  Cells       Date:  2019-03-11       Impact factor: 6.600

6.  Sex-Dependent Dyslipidemia and Neuro-Humoral Alterations Leading to Further Cardiovascular Risk in Juvenile Obesity.

Authors:  Estefania Simoes; Joanna Correia-Lima; Elie Leal de Barros Calfat; Thais Zélia Dos Santos Otani; Daniel Augusto Correa Vasques; Victor Henrique Oyamada Otani; Pamela Bertolazzi; Cristiane Kochi; Marilia Seelaender; Ricardo Riyoiti Uchida
Journal:  Front Nutr       Date:  2021-02-12

7.  Determinants of elevated chemerin as a novel biomarker of immunometabolism: data from a large population-based cohort.

Authors:  Liselot Koelman; Robin Reichmann; Claudia Börnhorst; Matthias B Schulze; Cornelia Weikert; Ronald Biemann; Berend Isermann; Andreas Fritsche; Krasimira Aleksandrova
Journal:  Endocr Connect       Date:  2021-09-20       Impact factor: 3.335

Review 8.  Sleep Disturbance and Metabolic Dysfunction: The Roles of Adipokines.

Authors:  Zhikui Wei; You Chen; Raghu P Upender
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 6.208

Review 9.  Chemerin as Potential Biomarker in Pediatric Diseases: A PRISMA-Compliant Study.

Authors:  Katarzyna Zdanowicz; Anna Bobrus-Chociej; Dariusz Marek Lebensztejn
Journal:  Biomedicines       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.